How this model should be used
The presented model is used to predict the preinterventional risk of aneurysmal rebleeding within 24 and 72 hours after aneurysmal subarachnoid hemorrhage. The prediction score has been developed based on multinational cohort data from two prospective hospital registries and three retrospective observational studies in Europe (n = 2075, of whom 269 suffered preinterventional rebleeding; DOI: 10.1227/neu.0000000000002045). The score has been externally validated using data from two European hospital registries (n = 1467, of whom 143 suffered preinterventional rebleeding; DOI: 10.1227/neu.0000000000003275).
Context information
Because this validation study used observational data, it is difficult to rule out selection- and information bias. Although the DCA suggests clinical usefulness, the real scientific test of how the ARISE models affect decision-making in daily clinical patient care is an impact study. This prediction tool should be used exclusively by health care professionals as a complementary tool to estimate the preinterventional rebleeding risk. Using it, you should understand and agree that the authors are not responsible or liable for any claim, loss, or damage resulting from its use. While we try to keep the model as accurate as possible, we disclaim any warranty concerning its accuracy, timeliness, and completeness, and any other warranty, express or implied, including warranties of merchantability or fitness for a particular purpose.
Model performance
The ARISE base model showed promise at external validation. The ARISE base model has good discriminative ability for the prediction of a preinterventional rebleed in patients suffering from aSAH (c-statistic >0.70), although updating the baseline hazard for each center was needed to obtain adequate model calibration. After local validation and adjustment of the baseline hazard if required, the ARISE base model may well be used for risk prediction in patients with aSAH facilitating future endeavors to minimize the risk of preinterventional rebleeding.
This algorithm is provided for educational, training and information purposes. It must not be used to support medical decision making, or to provide medical or diagnostic services. Read our full Disclaimer.
{{ (typeof row === 'object') ? row.label : row }} |
{{ result.result }}
|
Evidencio B.V., Irenesingel 19, 7481 GJ Haaksbergen, The Netherlands |
|
{{ model.lot }} |
{{ model.electronicLabelWarning }} | |
|
{{ model.udi }} |
|
{{ model.representative }} |
|
Download the User manual |
|
Medical device In vitro diagnostic medical device |
Please enter a password
A password has to be at least 8 characters.
A password cannot be longer then 64 characters.
Choose a password with at least one capital letter.
Choose a password with at least one special character (@$!%*#?&)
Please agree to the Terms & Conditions and the Disclaimer
Please provide your e-mail address and we'll send you a link to reset your password.
Email Address
Please enter a valid email
If an account was registered with this email address you will receive a recovery link in your mail.
Please use the reset password link in it to set your new password.
Didn't receive the email yet? Please check your spam folder, or resend the email.